공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 수산양식 치료 시장 조사 보고서 : 제품별, 최종사용자별 예측(-2025년) - COVID-19의 누적적 영향

Aquaculture Therapeutics Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 995387
페이지 정보 영문 190 Pages
가격
US $ 3,949 ₩ 4,457,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,586,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,715,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 8,972,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,230,000 PDF (Enterprise License) + Excel


세계의 수산양식 치료 시장 조사 보고서 : 제품별, 최종사용자별 예측(-2025년) - COVID-19의 누적적 영향 Aquaculture Therapeutics Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 190 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 수산양식 치료 시장 규모는 2020년 19억 5,468만 달러에서 2025년말까지 28억 8,567만 달러로 확대할 것으로 예상되고 있습니다.

COVID-19는 거의 모든 업계에 영향을 미친 비할 데 없는 세계의 공중보건비상사태이므로 예측 기간 중 업계의 성장에 장기적인 영향을 미칠 것으로 예측됩니다.

세계의 수산양식 치료 시장에 대해 조사했으며, 시장의 기회 및 과제, 성장 및 억제요인, COVID-19의 누적적 영향, 최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 커버리지
  • 조사 기간
  • 통화와 가격
  • 언어
  • 제약 사항
  • 이해관계자

제2장 조사 방법

  • 조사 프로세스
    • 정의 : 조사 목적
    • 결정 : 조사 계획
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 리포트
    • 반복 : 리포트 업데이트
  • 조사 시행
    • 개시 : 조사 프로세스
    • 계획 : 조사 계획 작성
    • 시행 : 조사 시행
    • 검증 : 발견과 분석
    • 출판물 : 조사보고
  • 조사 성과

제3장 개요

  • 시장 전망
  • 제품별 시장 전망
  • 최종사용자별 시장 전망
  • 지역별 시장 전망
  • 경쟁사 전망

제4장 시장 개요

  • COVID-19의 누적적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장요인
    • 억제요인
    • 시장 기회
    • 과제
  • Porter의 산업 분석

제6장 제품별 시장

  • 융모성 생식선자극호르몬(Chorionic Gonadotropin)
  • Florfenicol
  • 포르말린 용액
  • 과산화수소
  • 옥시테트라사이클린
  • Tricaine Methane Sulfonate

제7장 최종사용자별 시장

  • E-Commerce
  • 수의 약국

제8장 아메리카 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제10장 유럽, 중동·아프리카 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제11장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 합의, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금조달
    • 상, 표창, 확대

제12장 기업 개요

  • Alpharma Inc.
  • Blue Ridge Aquaculture
  • Cermaq ASA
  • Cooke Aquaculture
  • Kona Bay Marine Resources
  • Nireus Aquaculture S.A
  • Nutreco Holding N.V.
  • Royal Greenland
  • Sea Watch International Ltd.
  • Seafood Company.
  • Selonda Aquaculture S.A.
  • StarKist Taylor Shellfish Inc.
  • Tassal group Ltd.
  • TriMarine International
  • TunaTech GmbH
  • Unima Group
  • ViAqua Therapeutics Ltd

제13장 부록

  • 디스커션 가이드
  • 라이선스와 가격
KSA 21.03.18

LIST OF FIGURES

  • FIGURE 1. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHORIONIC GONADOTROPIN, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHORIONIC GONADOTROPIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FLORFENICOL, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FLORFENICOL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FORMALIN SOLUTION, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FORMALIN SOLUTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HYDROGEN PEROXIDE, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HYDROGEN PEROXIDE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OXYTETRACYCLINE, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OXYTETRACYCLINE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TRICAINE METHANE SULFONATE, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TRICAINE METHANE SULFONATE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2026
  • FIGURE 25. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY E COMMERCE, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY E COMMERCE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VETERINARY PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 30. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 32. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. CALIFORNIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. FLORIDA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. ILLINOIS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. NEW YORK AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. OHIO AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. PENNSYLVANIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. TEXAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 45. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 47. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 58. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL AQUACULTURE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 71. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AQUACULTURE THERAPEUTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL AQUACULTURE THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHORIONIC GONADOTROPIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FLORFENICOL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FORMALIN SOLUTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HYDROGEN PEROXIDE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OXYTETRACYCLINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TRICAINE METHANE SULFONATE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY E COMMERCE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VETERINARY PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CALIFORNIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CALIFORNIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. FLORIDA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. FLORIDA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ILLINOIS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ILLINOIS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. NEW YORK AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. NEW YORK AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. OHIO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. OHIO AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. PENNSYLVANIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. PENNSYLVANIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. TEXAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. TEXAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SCORES
  • TABLE 86. GLOBAL AQUACULTURE THERAPEUTICS MARKET: BUSINESS STRATEGY
  • TABLE 87. GLOBAL AQUACULTURE THERAPEUTICS MARKET: PRODUCT SATISFACTION
  • TABLE 88. GLOBAL AQUACULTURE THERAPEUTICS MARKET: RANKING
  • TABLE 89. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 90. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 91. GLOBAL AQUACULTURE THERAPEUTICS MARKET: MERGER & ACQUISITION
  • TABLE 92. GLOBAL AQUACULTURE THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 93. GLOBAL AQUACULTURE THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 94. GLOBAL AQUACULTURE THERAPEUTICS MARKET: INVESTMENT & FUNDING
  • TABLE 95. GLOBAL AQUACULTURE THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 96. GLOBAL AQUACULTURE THERAPEUTICS MARKET: LICENSE & PRICING
  • TABLE 97. GLOBAL AQUACULTURE THERAPEUTICS MARKET: CONTACT DETAILS

The Global Aquaculture Therapeutics Market size was estimated at USD 1,954.68 Million in 2020 and expected to reach USD 2,122.82 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.94% to reach USD 3,267.47 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Aquaculture Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Aquaculture Therapeutics Market was studied across Chorionic Gonadotropin, Florfenicol, Formalin Solution, Hydrogen Peroxide, Oxytetracycline, and Tricaine Methane Sulfonate.

Based on End User, the Aquaculture Therapeutics Market was studied across E Commerce and Veterinary Pharmacies.

Based on Geography, the Aquaculture Therapeutics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Aquaculture Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Aquaculture Therapeutics Market, including Alpharma Inc., Blue Ridge Aquaculture, Cermaq ASA, Cooke Aquaculture, Kona Bay Marine Resources, Nireus Aquaculture S.A, Nutreco Holding N.V., Royal Greenland, Sea Watch International Ltd., Seafood Company., Selonda Aquaculture S.A., StarKist Taylor Shellfish Inc., Tassal group Ltd., TriMarine International, TunaTech GmbH, Unima Group, and ViAqua Therapeutics Ltd.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Aquaculture Therapeutics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Aquaculture Therapeutics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Aquaculture Therapeutics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Aquaculture Therapeutics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Aquaculture Therapeutics Market?
  • 6. What is the market share of the leading vendors in the Global Aquaculture Therapeutics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Aquaculture Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. End User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aquaculture industry
      • 5.1.1.2. Rising bacterial disease affecting the animals cultured in the aquaculture
      • 5.1.1.3. Growing demand for effective aquaculture therapeutic drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Risks of therapeutics to the aquatics and the consumer
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs
      • 5.1.3.2. Extensive government initiatives to support R&D in aquaculture therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations to approve aquaculture therapeutics
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Aquaculture Therapeutics Market, by Product

  • 6.1. Introduction
  • 6.2. Chorionic Gonadotropin
  • 6.3. Florfenicol
  • 6.4. Formalin Solution
  • 6.5. Hydrogen Peroxide
  • 6.6. Oxytetracycline
  • 6.7. Tricaine Methane Sulfonate

7. Aquaculture Therapeutics Market, by End User

  • 7.1. Introduction
  • 7.2. E Commerce
  • 7.3. Veterinary Pharmacies

8. Americas Aquaculture Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Aquaculture Therapeutics Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Aquaculture Therapeutics Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Alpharma Inc.
  • 12.2. Blue Ridge Aquaculture
  • 12.3. Cermaq ASA
  • 12.4. Cooke Aquaculture
  • 12.5. Kona Bay Marine Resources
  • 12.6. Nireus Aquaculture S.A
  • 12.7. Nutreco Holding N.V.
  • 12.8. Royal Greenland
  • 12.9. Sea Watch International Ltd.
  • 12.10. Seafood Company.
  • 12.11. Selonda Aquaculture S.A.
  • 12.12. StarKist Taylor Shellfish Inc.
  • 12.13. Tassal group Ltd.
  • 12.14. TriMarine International
  • 12.15. TunaTech GmbH
  • 12.16. Unima Group
  • 12.17. ViAqua Therapeutics Ltd

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details
Back to Top
전화 문의
F A Q